On this page of StockholderLetter.com we present the latest annual shareholder letter from DocGo Inc. — ticker symbol DCGO. Reading current and past DCGO letters to shareholders can bring important insights into the investment thesis.
ANNUAL REPORT 2023 LEADING THE PROACTIVE HEALTHCARE REVOLUTION

BOARD OF DIRECTORS Steven Katz 1, 2, 3 Chair of the Board of DocGo Inc. President of Steven Katz & Associates, Inc., a life sciences/healthcare and technology-based management consulting firm. Lee Bienstock Director Chief Executive Officer of DocGo Inc. Ely D. Tendler Director General Counsel and Secretary of DocGo Inc. Vina Leite 2, 3 Director Chief People Officer of GoodRx, Inc., a publicly traded company that offers digital resources for healthcare. Michael Burdiek 1 Director Former Chief Executive Officer and Director of Motion Acquisition Corp. and current board member and advisor to public and private technology growth companies. Ira Smedra 1, 2, 3 Director Founder and President of the ARBA Group, a real estate investment company with a healthcare portfolio including more than 150 skilled nursing facilities located in eight states and two acute care hospitals. James M. Travers Director Former Chairman of Motion Acquisition Corp. and former executive at technology and software companies. 1 Member of the Audit and Compliance Committee 2 Member of the Compensation Committee 3 Member of the Nominating and Corporate Governance Committee EXECUTIVE OFFICERS Lee Bienstock Chief Executive Officer Ely Tendler General Counsel and Secretary Norman Rosenberg Chief Financial Officer and Treasurer Stephen Sugrue Chief Compliance Officer The letters that follow include forward-looking statements within the meaning of SEC rules. All statements other than statements of historical fact, including, without limitation, statements regarding the Company s business strategy and plans, and objectives and goals of management for future operations are forward-looking statements. For more information about the risks associated with forward-looking statements, please see the Risk Factors and Management s Discussion and Analysis of Financial Condition and Results of Operations sections of this Annual Report on Form 10-K.

Dear Fellow Shareholders: It has been my privilege to serve as a member of the DocGo board of directors since 2021, and I am honored by my recent appointment to Chairman. It continues to be a great pleasure to work with this dynamic company, which is led by an enormously talented management team. I look forward to helping provide guidance to our team to accomplish new milestones in 2024 and beyond. Our company is on a mission to provide high quality, highly accessible healthcare for all. This noble mission has resonated with our many customers, and has helped drive continued business growth and record-breaking revenues for DocGo in 2023. Our company is working tirelessly to create a more patient-centric healthcare experience. I am continually impressed and highly encouraged by how engaged and committed our team is. There is unrelenting energy in our company a drive to innovate, to constantly raise the bar, and to challenge oneself to deliver more value for our shareholders, for our customers, and for the patients in our care. Sincerely, Steven Katz Chairman DocGo
 • shareholder letter icon 4/25/2024 Letter Continued (Full PDF)
 • stockholder letter icon 4/26/2023 DCGO Stockholder Letter
 • stockholder letter icon More "Diagnostics" Category Stockholder Letters
 • Benford's Law Stocks icon DCGO Benford's Law Stock Score = 77


DCGO Shareholder/Stockholder Letter Transcript:

ANNUAL
REPORT
2023
LEADING THE PROACTIVE HEALTHCARE REVOLUTION


BOARD OF DIRECTORS
Steven Katz 1, 2, 3
Chair of the Board of DocGo Inc.
President of Steven Katz & Associates, Inc., a life
sciences/healthcare and technology-based
management consulting firm.
Lee Bienstock
Director
Chief Executive Officer of DocGo Inc.
Ely D. Tendler
Director
General Counsel and Secretary of DocGo Inc.
Vina Leite 2, 3
Director
Chief People Officer of GoodRx, Inc., a publicly
traded company that offers digital resources
for healthcare.
Michael Burdiek 1
Director
Former Chief Executive Officer and Director
of Motion Acquisition Corp. and current
board member and advisor to public and private
technology growth companies.
Ira Smedra 1, 2, 3
Director
Founder and President of the ARBA Group,
a real estate investment company with a
healthcare portfolio including more than 150
skilled nursing facilities located in eight states
and two acute care hospitals.
James M. Travers
Director
Former Chairman of Motion Acquisition Corp.
and former executive at technology and
software companies.
1 Member of the Audit and Compliance Committee
2 Member of the Compensation Committee
3 Member of the Nominating and Corporate Governance Committee
EXECUTIVE OFFICERS
Lee Bienstock
Chief Executive Officer
Ely Tendler
General Counsel and Secretary
Norman Rosenberg
Chief Financial Officer and Treasurer
Stephen Sugrue
Chief Compliance Officer
The letters that follow include forward-looking statements within the meaning of SEC rules. All statements other than statements of historical fact,
including, without limitation, statements regarding the Company   s business strategy and plans, and objectives and goals of management for future
operations are forward-looking statements. For more information about the risks associated with forward-looking statements, please see the    Risk
Factors    and    Management   s Discussion and Analysis of Financial Condition and Results of Operations    sections of this Annual Report on Form 10-K.


Dear Fellow Shareholders:
It has been my privilege to serve as a member of the DocGo
board of directors since 2021, and I am honored by my
recent appointment to Chairman. It continues to be a great
pleasure to work with this dynamic company, which is led by
an enormously talented management team. I look forward to
helping provide guidance to our team to accomplish new
milestones in 2024 and beyond.
Our company is on a mission to provide high quality, highly
accessible healthcare for all. This noble mission has
resonated with our many customers, and has helped drive
continued business growth and record-breaking revenues
for DocGo in 2023.
Our company is working tirelessly to create a more
patient-centric healthcare experience. I am continually
impressed and highly encouraged by how engaged and
committed our team is. There is unrelenting energy in our
company     a drive to innovate, to constantly raise the bar,
and to challenge oneself to deliver more value     for our
shareholders, for our customers, and for the patients in
our care.
Sincerely,
Steven Katz
Chairman
DocGo



shareholder letter icon 4/25/2024 Letter Continued (Full PDF)
 

DCGO Stockholder/Shareholder Letter (DocGo Inc.) | www.StockholderLetter.com
Copyright © 2023 - 2024, All Rights Reserved

Nothing in StockholderLetter.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy.